Zuluita, Shairah M.

HRN: 22-35-06  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/22/2022
12/28/2022
IV
350mg
Q6Hrs
PCAP-C; Tc PTB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: